Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Edwards Lifesciences Corp (EW)
Sector: Healthcare; Industry: Medical Devices

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2008-11-24 WANG HUIMIN CVP, Japan & Intercontinental Sell 10,000 $48.88 $488,800 Yes
2008-11-18 LYLE CORINNE H CVP & Pres., Global Ops Sell 8,561 $52.00 $445,172 Yes
2008-11-14 Verguet Patrick B CVP, Europe Sell 2,250 $55.00 $123,750 Yes
2008-11-10 MUSSALLEM MICHAEL A Chairman & CEO Sell 14,000 $53.67 $751,380 Yes
2008-11-10 Wood Larry L CVP, THV Replacement Sell 16,000 $53.68 $858,922 Yes
2008-10-23 LYLE CORINNE H CVP & Pres., Global Ops Sell 10,000 $51.12 $511,239 Yes
2008-10-10 MUSSALLEM MICHAEL A Chairman & CEO Sell 14,000 $49.78 $696,933 Yes
2008-09-10 MUSSALLEM MICHAEL A Chairman & CEO Sell 14,000 $57.27 $801,753 Yes
2008-08-25 REINDL ROBERT C CVP, H.R. and Communications Sell 10,110 $59.30 $599,547 Yes
2008-08-19 Solomon Carlyn D CVP, Critical Care & Vascular Sell 1,509 $60.00 $90,540 No
2008-08-12 NEAL PHILIP M Director Sell 1,039 $59.07 $61,376 Yes

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.